| Literature DB >> 31423163 |
Yaping Ren1, Wenhua Shao2,3, Lijun Zuo1, Wei Zhao1, Haizhang Qin1, Yingjie Hua1, Dejie Lu1, Chao Mi3, Sien Zeng2,3, Liao Zu4.
Abstract
Cadmium is a heavy metal that is toxic to humans and the reproductive system. The present study aimed to investigate the mechanisms of cadmium-induced reproductive toxicity in a male Institute of Cancer Research mouse model of cadmium poisoning. Changes in luteinizing hormone receptor (LHR), 17α-hydroxylase and endothelial nitric oxide (NO) synthase (eNOS) expression levels were examined. A total of 24 male mice (4-week-old) were randomly divided into four groups (normal control group and low, medium and high cadmium groups) and subjected to gavage treatment with normal saline or cadmium-containing saline solutions for 8 weeks prior to sacrifice. To assess testicular injury, serum androgen levels were determined by ELISA, testicular tissue pathological changes were evaluated using hematoxylin and eosin staining. In addition, LHR, 17α-hydroxylase and eNOS expressions levels were examined by western blotting, and apoptosis was examined with a terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The results demonstrated that the severity of testes injury increased with cadmium concentration. In addition, LHR, 17α-hydroxylase and eNOS expression levels increased with low and medium concentrations of cadmium; however, they were decreased following treatment with high concentrations of cadmium. The results from the present study demonstrated that cadmium altered LHR, 17α-hydroxylase and eNOS expression levels in testicular stromal cells, which may impact testosterone synthesis. Furthermore, NO was suggested to be involved in cadmium-induced testicular injury by measurements of eNOS expression in testicular stromal cells.Entities:
Keywords: 17α-hydroxylase; androgen; endothelial nitric oxide synthase; luteinizing hormone receptor; spermatogenesis
Year: 2019 PMID: 31423163 PMCID: PMC6607104 DOI: 10.3892/ol.2019.10418
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Figure 1.Experiment protocol used in the present study.
Figure 2.Body weight and serum androgen levels of mice in the different groups. (A) Body weights of the four groups of mice. (B) Serum androgen levels of the four groups of mice. The four groups were as follows: Normal control group (gavage-fed with saline); low-concentration cadmium toxicity group (2 mg/kg body weight); medium-concentration cadmium toxicity group (4 mg/kg body weight); and high-concentration cadmium toxicity group (8 mg/kg body weight). Data is presented as the mean ± standard deviation. *P<0.05 vs. control group.
Figure 3.Influence of cadmium on testicular tissue protein levels and apoptosis of testicular cells. (A) H&E staining revealed testicular morphology. Immunohistochemical staining demonstrated that the testicular morphology and expression levels of LHR, 17α-hydroxylase and eNOS were altered in testicular tissues following administration of different concentrations of cadmium. Magnification, ×400. (B) The effect of cadmium on testicular cell apoptosis was measured by the TUNEL assay. The number of TUNEL-positive nuclei following cadmium treatment was increased in a concentration-dependent manner, which indicated elevated rates of apoptosis. Magnification, ×400. (C) Expression levels of LHR, 17α-hydroxylase, eNOS and TUNEL in testicular tissues following administration of different concentrations of cadmium. Data are presented as the mean ± standard deviation. *P<0.05, **P<0.01 vs. control group. eNOS, endothelial nitric oxide synthase; LHR, luteinizing hormone receptor; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; H&E, hematoxylin and eosin.
Expression levels of LHR, 17α-hydroxylase, eNOS and TUNEL in testicular tissues.
| Group | 17-α-hydroxylase | LHR | eNOS | TUNEL |
|---|---|---|---|---|
| Control | 0.67±0.47 | 0.33±0.18 | 1.17±0.41 | 1.00±0.63 |
| 2 mg/kg | 2.17±0.75[ | 1.83±0.75[ | 1.83±0.75 | 2.00±0.63[ |
| 4 mg/kg | 1.67±0.52 | 2.00±0.63[ | 2.17±0.75 | 2.67±0.52[ |
| 8 mg/kg | 0.50±0.45 | 1.00±0.63 | 0.83±0.75 | 2.83±0.41[ |
P<0.05
P<0.01 vs. control group. eNOS, endothelial nitric oxide; LHR, luteinizing hormone receptor; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
Figure 4.Influence of cadmium on Leydig cell protein expression levels determined by western blotting. (A) Expression levels of LHR, 17α-hydroxylase and eNOS were altered in testicular tissues following administration of different concentrations of cadmium. (B) Quantification of the expression levels of LHR, 17α-hydroxylase and eNOS in testicular tissues following administration of different concentrations of cadmium. Data are presented as the mean ± standard deviation. *P<0.05, **P<0.01 vs. corresponding control group. eNOS, endothelial nitric oxide synthase; LHR, luteinizing hormone receptor.
Figure 5.Schematic model of the potential role of cadmium on testicular injury. In the present study, LHR, 17α-hydroxylase and eNOS levels were revealed to be elevated in the low and medium dose groups. Their levels were low in the high dose group. Expression levels of LHR and 17α-hydroxylase were consistent and were higher in the low and medium dose groups compared with in the control group. eNOS expression was the highest in the medium dose group. The increased expression levels of LHR, 17α-hydroxylase and eNOS in the low and medium dose groups may inhibit the apoptosis of testicular cells caused by cadmium. The decreased expression levels of all factor in the high dose group may be the result of the increased apoptosis of testicular cells. eNOS, endothelial nitric oxide synthase; LHR, luteinizing hormone receptor; NO, nitric oxide.